- Home
- MRK vs SENEB Comparison
MRK vs SENEB Comparison
Compare MRK & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | SENEB |
|---|---|---|
| Founded | 2000 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | 813.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | SENEB |
|---|---|---|
| Price | $108.57 | $109.80 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $111.93 | N/A |
| AVG Volume (30 Days) | ★ 13.9M | 447.0 |
| Earning Date | 02-03-2026 | 02-05-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | ★ 58.08 | 47.79 |
| EPS | 7.56 | ★ 8.61 |
| Revenue | ★ $64,235,000,000.00 | $1,606,175,000.00 |
| Revenue This Year | $1.98 | N/A |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | $14.41 | ★ $12.68 |
| Revenue Growth | 1.68 | ★ 8.33 |
| 52 Week Low | $73.31 | $71.47 |
| 52 Week High | $110.17 | $124.94 |
Technical Indicators
Market Signals| Indicator | MRK | SENEB |
|---|---|---|
| Relative Strength Index (RSI) | 71.72 | 49.78 |
| Support Level | $104.43 | $109.56 |
| Resistance Level | $107.59 | $115.00 |
| Average True Range (ATR) | 2.09 | 0.39 |
| MACD | 0.20 | -1.66 |
| Stochastic Oscillator | 80.22 | 6.89 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About SENEB Seneca Foods Corp. Class B
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.